Published in PLoS One on May 31, 2012
Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin. Cancer Res (2013) 0.95
PubChem applications in drug discovery: a bibliometric analysis. Drug Discov Today (2014) 0.95
Signal transduction and molecular targets of selected flavonoids. Antioxid Redox Signal (2013) 0.83
Caffeic acid directly targets ERK1/2 to attenuate solar UV-induced skin carcinogenesis. Cancer Prev Res (Phila) (2014) 0.80
Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells. Mol Carcinog (2014) 0.79
(+)-2-(1-Hydroxyl-4-oxocyclohexyl) ethyl caffeate suppresses solar UV-induced skin carcinogenesis by targeting PI3K, ERK1/2, and p38. Cancer Prev Res (Phila) (2014) 0.79
Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro Evidences. PLoS One (2015) 0.78
Pharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants. Drug Des Devel Ther (2016) 0.75
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model (2005) 16.75
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (1997) 10.90
Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem (1987) 10.61
Advances in flavonoid research since 1992. Phytochemistry (2000) 7.78
Flavonoids as antioxidants. J Nat Prod (2000) 6.02
Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell (2000) 5.23
Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev (1998) 4.50
Diverse, high-quality test set for the validation of protein-ligand docking performance. J Med Chem (2007) 3.03
Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res (2005) 2.70
Structure-based virtual screening: an overview. Drug Discov Today (2002) 2.70
Protein flexibility in ligand docking and virtual screening to protein kinases. J Mol Biol (2004) 2.65
Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther (2001) 2.51
Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol (1999) 2.16
The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation. Cancer Res (2005) 1.89
Phytoestrogens: a review of the present state of research. Phytother Res (2003) 1.79
Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer (2011) 1.69
Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health. Biotechnol J (2007) 1.35
Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase. Mol Cancer Ther (2007) 1.33
Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation. Cancer Res (2007) 1.33
Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Mol Cancer Res (2003) 1.32
Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res (2008) 1.30
Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res (2008) 1.29
[6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Res (2009) 1.26
From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective. Curr Opin Drug Discov Devel (2008) 1.24
Dietary flavonoid intake and lung cancer--a population-based case-control study. Cancer (2008) 1.10
A regulatory mechanism for RSK2 NH(2)-terminal kinase activity. Cancer Res (2009) 1.07
Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression. Carcinogenesis (2008) 1.07
Essential role of RSK2 in c-Fos-dependent osteosarcoma development. J Clin Invest (2005) 1.05
Structural basis for activation of the autoinhibitory C-terminal kinase domain of p90 RSK2. Nat Struct Mol Biol (2007) 1.04
Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase. Cancer Res (2010) 1.04
Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity. Biochem Pharmacol (2010) 1.03
A novel role for mixed-lineage kinase-like mitogen-activated protein triple kinase alpha in neoplastic cell transformation and tumor development. Cancer Res (2004) 1.01
Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Cancer Prev Res (Phila) (2011) 1.00
Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. Carcinogenesis (2011) 0.97
Leukotriene A4 hydrolase as a target for cancer prevention and therapy. Curr Cancer Drug Targets (2004) 0.97
Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation. J Biol Chem (2010) 0.97
Isoflavonoids in non-leguminous families: an update. Nat Prod Rep (2005) 0.96
Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K. Cancer Prev Res (Phila) (2011) 0.96
Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase. Carcinogenesis (2009) 0.96
6,7,4'-trihydroxyisoflavone inhibits HCT-116 human colon cancer cell proliferation by targeting CDK1 and CDK2. Carcinogenesis (2011) 0.93
Myricetin suppresses UVB-induced wrinkle formation and MMP-9 expression by inhibiting Raf. Biochem Pharmacol (2010) 0.87
7,3',4'-Trihydroxyisoflavone inhibits epidermal growth factor-induced proliferation and transformation of JB6 P+ mouse epidermal cells by suppressing cyclin-dependent kinases and phosphatidylinositol 3-kinase. J Biol Chem (2010) 0.87
Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo. Carcinogenesis (2009) 0.86
An integrated database of flavonoids. Biofactors (2006) 0.86
Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2. PLoS One (2009) 0.84
Quantum chemical associations ligand-residue: their role to predict flavonoid binding sites in proteins. J Chem Inf Model (2010) 0.78
Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol (2007) 8.14
Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer (2004) 6.67
Comparative genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene. Cell (2004) 6.10
Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex. Nature (2008) 5.78
Nucleation, propagation and cleavage of target RNAs in Ago silencing complexes. Nature (2009) 5.24
Yng1 PHD finger binding to H3 trimethylated at K4 promotes NuA3 HAT activity at K14 of H3 and transcription at a subset of targeted ORFs. Mol Cell (2006) 3.87
Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol Cell (2006) 3.62
Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature (2009) 3.13
Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a variability and diagnostic performance study. Ophthalmology (2009) 2.96
WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity. Nature (2008) 2.86
Studies on the structure and dynamics of the human telomeric G quadruplex by single-molecule fluorescence resonance energy transfer. Proc Natl Acad Sci U S A (2003) 2.82
Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions. Cell (2011) 2.68
Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression. Cell (2010) 2.44
Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J Biol Chem (2003) 2.30
Histone H3 recognition and presentation by the WDR5 module of the MLL1 complex. Nat Struct Mol Biol (2006) 2.29
Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol (2005) 2.21
ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome. Nat Struct Mol Biol (2011) 2.18
Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev (2009) 2.15
Structural and functional insights into 5'-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat Struct Mol Biol (2010) 2.13
Mitogen-activated protein kinase activation in UV-induced signal transduction. Sci STKE (2003) 2.12
Evaluation of retinal nerve fiber layer progression in glaucoma: a study on optical coherence tomography guided progression analysis. Invest Ophthalmol Vis Sci (2009) 1.86
Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res (2010) 1.82
Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (2002) 1.77
The functional contrariety of JNK. Mol Carcinog (2007) 1.77
Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model. Clin Cancer Res (2007) 1.73
Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer (2011) 1.69
(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res (2006) 1.60
Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population. Bone (2008) 1.59
Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells. Gastroenterology (2007) 1.51
Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cells. Stem Cells (2010) 1.48
Anterior chamber angle measurement with anterior segment optical coherence tomography: a comparison between slit lamp OCT and Visante OCT. Invest Ophthalmol Vis Sci (2008) 1.48
Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model. Cancer Prev Res (Phila) (2013) 1.45
Calcium-activated RAF/MEK/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by alpha B-crystallin through inhibition of RAS activation. Mol Biol Cell (2005) 1.45
In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells (2012) 1.44
The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett (2006) 1.43
Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res (2002) 1.39
The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit Rev Oncol Hematol (2002) 1.37
Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis. Cell (2013) 1.35
The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J Biol Chem (2005) 1.34
Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation. Cancer Res (2007) 1.33
ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4. Nat Struct Mol Biol (2012) 1.30
Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res (2008) 1.30
Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res (2008) 1.29
Tpl2 is a key mediator of arsenite-induced signal transduction. Cancer Res (2009) 1.26
Inducible covalent posttranslational modification of histone H3. Sci STKE (2005) 1.26
[6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Res (2009) 1.26
Dynamic analysis of iris configuration with anterior segment optical coherence tomography. Invest Ophthalmol Vis Sci (2010) 1.23
Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas. Oncogene (2004) 1.23
Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. Cancer Prev Res (Phila) (2011) 1.20
Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation. Cancer Res (2008) 1.20
Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation. Cancer Res (2005) 1.20
Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways. Cancer Res (2003) 1.20
The clinical applications of multifocal electroretinography: a systematic review. Surv Ophthalmol (2007) 1.20
Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers. Carcinogenesis (2005) 1.19
Identification of a new RNA.RNA interaction site for human telomerase RNA (hTR): structural implications for hTR accumulation and a dyskeratosis congenita point mutation. Nucleic Acids Res (2003) 1.19
RSK2 mediates muscle cell differentiation through regulation of NFAT3. J Biol Chem (2007) 1.19
Quantitative monitoring of adenocarcinoma development in rodents by magnetic resonance imaging. Clin Cancer Res (2008) 1.18
Identification of a novel splice-site mutation in MIP in a Chinese congenital cataract family. Mol Vis (2009) 1.17
Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol Carcinog (2008) 1.17
Special fasciculiform cataract caused by a mutation in the gammaD-crystallin gene. Mol Vis (2004) 1.17
Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models. Oncogene (2004) 1.16
Single-molecule analysis of human telomerase monomer. Nat Chem Biol (2008) 1.16
Polypoidal choroidal vasculopathy in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol (2004) 1.16
p85alpha acts as a novel signal transducer for mediation of cellular apoptotic response to UV radiation. Mol Cell Biol (2007) 1.15
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells. Breast Cancer Res (2008) 1.14
Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation. Cancer Epidemiol Biomarkers Prev (2007) 1.14
Regulation of microRNAs by epigenetics and their interplay involved in cancer. J Exp Clin Cancer Res (2013) 1.14
A novel mutation in the major intrinsic protein (MIP) associated with autosomal dominant congenital cataracts in a Chinese family. Mol Vis (2010) 1.13
Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis. Clin Cancer Res (2004) 1.13
Signal transduction pathways: targets for green and black tea polyphenols. J Biochem Mol Biol (2003) 1.12
Cancer prevention research - then and now. Nat Rev Cancer (2009) 1.12
The tumor suppressor p16(INK4a) prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity. Nat Struct Mol Biol (2005) 1.12
Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. Carcinogenesis (2007) 1.11